Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
291.6 INR | +0.71% | +9.15% | +16.82% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Sales 2024 * | 145B 1.74B | Sales 2025 * | 166B 1.99B | Capitalization | 346B 4.15B |
---|---|---|---|---|---|
Net income 2024 * | 9.49B 114M | Net income 2025 * | 9.3B 112M | EV / Sales 2024 * | 3.34 x |
Net Debt 2024 * | 139B 1.67B | Net Debt 2025 * | 143B 1.72B | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
36.4
x | P/E ratio 2025 * |
40.5
x | Employees | 16,545 |
Yield 2024 * |
0.46% | Yield 2025 * |
0.49% | Free-Float | 37.3% |
Latest transcript on Biocon Limited
1 day | +0.71% | ||
1 week | +9.15% | ||
Current month | +10.41% | ||
1 month | +13.17% | ||
3 months | +12.74% | ||
6 months | +29.97% | ||
Current year | +16.82% |
Managers | Title | Age | Since |
---|---|---|---|
Siddharth Mittal
CEO | Chief Executive Officer | 46 | 13-04-30 |
Peter Bains
CEO | Chief Executive Officer | 65 | 22-12-11 |
Chairman | 71 | 78-11-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 78-11-28 | |
Director/Board Member | 69 | 99-12-31 | |
Director/Board Member | 60 | 18-07-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 291.6 | +0.71% | 7 923 803 |
24-04-24 | 289.6 | +3.37% | 24,783,740 |
24-04-23 | 280.2 | +3.32% | 10,392,190 |
24-04-22 | 271.2 | +3.63% | 8,601,670 |
24-04-19 | 261.6 | -2.08% | 5,479,033 |
Delayed Quote NSE India S.E., April 25, 2024 at 06:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.82% | 4.15B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.80% | 22.2B | |
-16.53% | 21.23B | |
-9.14% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- BIOCON Stock